Migraine Treatment System with AI-Powered Personalized Dosing and IoT-Blockchain Integration

A novel migraine treatment system integrating AI-powered personalized dosing, IoT-enabled wearable devices, and blockchain-based patient data management to provide more effective and targeted treatment outcomes.

Migraine is a prevalent and debilitating neurological condition with significant unmet needs for effective treatments. The original patent disclosed a method for acute treatment of migraine using ubrogepant, but it has limitations in terms of personalized dosing and real-time tracking. The present inventive concept addresses these limitations by combining AI, IoT, and blockchain technologies to create a more powerful and effective system for migraine treatment.

The migraine treatment system comprises a wearable IoT device that detects migraine onset and transmits the detection to a blockchain-based patient database. The database triggers an AI-powered personalized dosing system, which optimizes the dose of ubrogepant based on the patient's medical history, genetic profile, and real-time health data. The customized dose is then transmitted to the patient's wearable IoT device for real-time tracking. The system also includes a blockchain-based platform for tracking treatment outcomes, using AI-powered analytics to identify trends and patterns.

The new claims introduce the novel combination of AI-powered personalized dosing, IoT-enabled wearable devices, and blockchain-based patient data management, which provides a more targeted and effective treatment approach compared to the original patent. The inventive step lies in the integration of these distinct technologies to create a synergistic system that overcomes the limitations of the original patent.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, varying IoT sensor configurations, or alternative blockchain platforms. Variations could also include the integration of additional technologies, such as machine learning or natural language processing, to further enhance the system's capabilities.

The migraine treatment system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine and digital health. The system's ability to provide more targeted and effective treatment outcomes could lead to increased adoption and revenue growth in these markets.